Guillermo H Giambartolomei

Title: Guillermo H Giambartolomei: Innovator in Vaccine Development

Introduction

Guillermo H Giambartolomei is a prominent inventor based in Buenos Aires, Argentina. He has made significant contributions to the field of vaccine development, holding a total of 2 patents. His work focuses on innovative adjuvants and chimeric proteins that enhance immune responses.

Latest Patents

Giambartolomei's latest patents include an adjuvant for vaccines that comprises a non-lipidated bacterial outer-membrane polypeptide (Omp). This adjuvant may be a modified polypeptide or include specific polypeptides such as Omp19S or Omp16S. Additionally, he has developed isolated chimeric proteins of modified lumazine synthase, which include multiple copies of peptides or protein domains. These innovations also encompass isolated nucleotide sequences, vectors, plasmids, and transformed cells for expressing the proteins. His patents further detail the production of monoclonal and polyclonal antibodies, as well as methods to induce immune responses in higher organisms.

Career Highlights

Throughout his career, Giambartolomei has worked with notable companies such as Inis Biotech LLC and Goldgene LLC. His expertise in vaccine technology and protein engineering has positioned him as a key figure in the biotechnology sector.

Collaborations

Giambartolomei has collaborated with esteemed colleagues, including Juliana Cassataro and Andres E Ibanez. These partnerships have contributed to the advancement of his research and the development of innovative solutions in immunology.

Conclusion

Guillermo H Giambartolomei is a distinguished inventor whose work in vaccine development and protein engineering has made a significant impact in the field. His patents reflect a commitment to advancing medical science and improving public health through innovative solutions.